Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Spratt

Showing results (101-110 of 498) with videos related to

Pageof 50
Sort By:
Clinical Nuclear Medicine|December 10, 2015
ACR Practice Parameter for the Performance of Therapy With Unsealed Radiopharmaceutical SourcesDaniel E Spratt, Bassem I Zaki, Benjamin L Franc, et al.
Current Opinion in Urology|October 5, 2019
Tissue-based genomics: which test and whenRandy A Vince, Jeffrey J Tosoian, William C Jackson, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2021
Exercise: A Treatment That Should Be Prescribed With Radiation TherapyNicholas G Zaorsky, Sara Garrett, Daniel E Spratt, et al.
International Journal of Radiation Oncology, Biology, Physics|April 11, 2019
STAMPEDE: Is Radiation Therapy to the Primary a New Standard of Care in Men with Metastatic Prostate Cancer?Ananya Choudhury, Ronald C Chen, Ann Henry, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|January 6, 2025
Impact of National Comprehensive Cancer Network Guidelines Inclusion of Level 1 Evidence on Insurance Denial for Randomized Controlled Trial Patients with Metastatic Spine DiseaseUlysses G Gardner, Melissa M Brately, Raed J Zuhour, et al.
Journal of Biopharmaceutical Statistics|September 22, 2017
Estimating the Optimal Personalized Treatment Strategy Based on Selected Variables to Prolong Survival via Random Survival Forest with Weighted BootstrapJincheng Shen, Lu Wang, Stephanie Daignault, et al.
The Journal of Urology|October 25, 2021
Development and Validation of an Improved Pathological Nodal Staging System in Men with Prostate CancerTimothy J Daskivich, Michael Luu, Stephen J Freedland, et al.
American Journal of Clinical Oncology|March 8, 2013
Image-guided radiation therapy for liver tumors: gastrointestinal histology mattersEvangelia Katsoulakis, Nadeem Riaz, Donald M Cannon, et al.
Prostate Cancer and Prostatic Diseases|September 3, 2021
Racial disparities in prostate cancer among black men: epidemiology and outcomesIlkania M Chowdhury-Paulino, Caroline Ericsson, Randy Vince, et al.
Prostate Cancer and Prostatic Diseases|January 8, 2025
Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancerPraful Ravi, Wanling Xie, Silke Gillessen, et al.
Pageof 50

Showing results (101-110 of 498) with videos related to

Sort By:
Pageof 50
Clinical Nuclear Medicine|December 10, 2015
ACR Practice Parameter for the Performance of Therapy With Unsealed Radiopharmaceutical SourcesDaniel E Spratt, Bassem I Zaki, Benjamin L Franc, et al.
Current Opinion in Urology|October 5, 2019
Tissue-based genomics: which test and whenRandy A Vince, Jeffrey J Tosoian, William C Jackson, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2021
Exercise: A Treatment That Should Be Prescribed With Radiation TherapyNicholas G Zaorsky, Sara Garrett, Daniel E Spratt, et al.
International Journal of Radiation Oncology, Biology, Physics|April 11, 2019
STAMPEDE: Is Radiation Therapy to the Primary a New Standard of Care in Men with Metastatic Prostate Cancer?Ananya Choudhury, Ronald C Chen, Ann Henry, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|January 6, 2025
Impact of National Comprehensive Cancer Network Guidelines Inclusion of Level 1 Evidence on Insurance Denial for Randomized Controlled Trial Patients with Metastatic Spine DiseaseUlysses G Gardner, Melissa M Brately, Raed J Zuhour, et al.
Journal of Biopharmaceutical Statistics|September 22, 2017
Estimating the Optimal Personalized Treatment Strategy Based on Selected Variables to Prolong Survival via Random Survival Forest with Weighted BootstrapJincheng Shen, Lu Wang, Stephanie Daignault, et al.
The Journal of Urology|October 25, 2021
Development and Validation of an Improved Pathological Nodal Staging System in Men with Prostate CancerTimothy J Daskivich, Michael Luu, Stephen J Freedland, et al.
American Journal of Clinical Oncology|March 8, 2013
Image-guided radiation therapy for liver tumors: gastrointestinal histology mattersEvangelia Katsoulakis, Nadeem Riaz, Donald M Cannon, et al.
Prostate Cancer and Prostatic Diseases|September 3, 2021
Racial disparities in prostate cancer among black men: epidemiology and outcomesIlkania M Chowdhury-Paulino, Caroline Ericsson, Randy Vince, et al.
Prostate Cancer and Prostatic Diseases|January 8, 2025
Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancerPraful Ravi, Wanling Xie, Silke Gillessen, et al.
Pageof 50